Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Healthcare Industry News CFO relocation signals Smith & Nephew’s U.S. pivot — but will investors buy the story? Smith & Nephew shifts CFO base to the U.S. as it doubles down on revenue leadership and margins. Find out what it means for investors and growth strategy. byPallavi MadhirajuSeptember 30, 2025